Plus therapeutics to provide update on respect™ clinical trials at the 27th annual scientific meeting and education day of the society for neuro-oncology

Recurrent glioblastoma and leptomeningeal metastases data have been selected for oral presentations

PSTV Ratings Summary

PSTV Quant Ranking